149 related articles for article (PubMed ID: 6418263)
1. A phase II study of intravesical mitomycin C in the treatment of superficial bladder cancer.
Harrison GS; Green DF; Newling DW; Richards B; Robinson MR; Smith PH
Br J Urol; 1983 Dec; 55(6):676-9. PubMed ID: 6418263
[TBL] [Abstract][Full Text] [Related]
2. Intravesical mitomycin C therapy for superficial bladder cancer. Report of a multicentre phase II study.
MacFarlane JR; Tolley DA
Br J Urol; 1985 Feb; 57(1):37-9. PubMed ID: 3918605
[TBL] [Abstract][Full Text] [Related]
3. Allergy to mitomycin C complicating topical administration for urothelial cancer.
Inglis JA; Tolley DA; Grigor KM
Br J Urol; 1987 Jun; 59(6):547-9. PubMed ID: 3120846
[TBL] [Abstract][Full Text] [Related]
4. Intravesical therapy of low stage bladder carcinoma with mitomycin C: comparison of results in untreated and previously treated patients.
Prout GR; Griffin PP; Nocks BN; DeFuria MD; Daly JJ
J Urol; 1982 Jun; 127(6):1096-8. PubMed ID: 6806488
[TBL] [Abstract][Full Text] [Related]
5. Use of intravesical cisplatin and mitomycin-C for recurrent transitional cell carcinoma of bladder refractory to thiotepa.
Mobley WC; Loening SA; Narayana AS; Culp DA
Urology; 1986 Apr; 27(4):335-9. PubMed ID: 3083555
[TBL] [Abstract][Full Text] [Related]
6. Mitomycin C resorption following repeated intravesical instillations using different instillation times.
van Helsdingen PJ; Rikken CH; Sleeboom HP; de Bruyn EA; Tjaden UR
Urol Int; 1988; 43(1):42-6. PubMed ID: 3131943
[TBL] [Abstract][Full Text] [Related]
7. Renal failure after intravesical mitomycin C.
Farha AJ; Krauss DJ
Urology; 1989 Oct; 34(4):216-7. PubMed ID: 2508290
[TBL] [Abstract][Full Text] [Related]
8. Treatment of superficial bladder cancer with intravesical mitomycin C: analysis of immediate and long-term response in 70 patients.
Soloway MS
J Urol; 1985 Dec; 134(6):1107-9. PubMed ID: 3932684
[TBL] [Abstract][Full Text] [Related]
9. Recurrence of superficial bladder carcinoma after intravesical instillation of mitomycin-C. Comparison of exposure times.
Giesbers AA; Van Helsdingen PJ; Kramer AE
Br J Urol; 1989 Feb; 63(2):176-9. PubMed ID: 2495144
[TBL] [Abstract][Full Text] [Related]
10. Role of intravesical mitomycin C in management of superficial bladder tumors.
Bracken RB; Swanson DA; Johnson DE; De Furia D; von Eschenbach AC; Crooke S
Urology; 1980 Jul; 16(1):11-5. PubMed ID: 7395004
[TBL] [Abstract][Full Text] [Related]
11. Intravesical mitomycin C for the treatment of recurrent superficial bladder tumours.
Hetherington JW; Newling DW; Robinson MR; Smith PH; Adib RS; Whelan P
Br J Urol; 1987 Mar; 59(3):239-41. PubMed ID: 3105631
[TBL] [Abstract][Full Text] [Related]
12. Bladder wall calcification after intravesical mitomycin C treatment of superficial bladder cancer.
Drago PC; Badalament RA; Lucas J; Drago JR
J Urol; 1989 Oct; 142(4):1071-2. PubMed ID: 2507794
[TBL] [Abstract][Full Text] [Related]
13. First-line chemotherapy of superficial bladder cancer: mitomycin vs thiotepa.
Heney NM
Urology; 1985 Oct; 26(4 Suppl):27-9. PubMed ID: 3931325
[TBL] [Abstract][Full Text] [Related]
14. Severe bladder contracture in patient receiving intravesical mitomycin C for superficial bladder cancer.
Baker WC; Russo MA; deVere White RW
Urology; 1987 Oct; 30(4):357-8. PubMed ID: 3116739
[TBL] [Abstract][Full Text] [Related]
15. The effect of mitomycin C on superficial bladder cancer.
Soloway MS; Murphy WM; DeFuria MD; Crooke S; Finebaum P
J Urol; 1981 May; 125(5):646-8. PubMed ID: 6785454
[TBL] [Abstract][Full Text] [Related]
16. Intravesical thiotepa and mitomycin C treatment immediately after transurethral resection and later for superficial (stages Ta and Tis) bladder cancer: a prospective, randomized, stratified study with crossover design.
Zincke H; Benson RC; Hilton JF; Taylor WF
J Urol; 1985 Dec; 134(6):1110-4. PubMed ID: 3932685
[TBL] [Abstract][Full Text] [Related]
17. [Complications of intravesical mitomycin chemotherapy, apropos of 2 clinical case reports].
Pouya M; Opsomer RJ; Wese FX; Saleh M; Donnay M; Van Cangh PJ
Acta Urol Belg; 1996 Mar; 64(1):47-53. PubMed ID: 8659335
[TBL] [Abstract][Full Text] [Related]
18. Intravesical thiotepa versus mitomycin C in patients with Ta, T1 and TIS transitional cell carcinoma of the bladder: a phase III prospective randomized study.
Heney NM; Koontz WW; Barton B; Soloway M; Trump DL; Hazra T; Weinstein RS
J Urol; 1988 Dec; 140(6):1390-3. PubMed ID: 3143016
[TBL] [Abstract][Full Text] [Related]
19. [Sequential intravesical chemotherapy with mitomycin C and adriamycin for superficial bladder tumor (preliminary report)].
Fukui I; Sekine H; Yamada T; Kihara K
Hinyokika Kiyo; 1985 Apr; 31(4):623-6. PubMed ID: 3929577
[TBL] [Abstract][Full Text] [Related]
20. Side effects associated with intravesical mitomycin.
Nissenkorn I; Herrod H; Soloway MS
J Urol; 1981 Nov; 126(5):596-7. PubMed ID: 6457917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
